Fibromyalgia: one year in review 2023

Area of Science:

• Rheumatology
• Neurology
• Pain Management

Background:

• Fibromyalgia (FM) is a widespread chronic pain condition affecting millions globally.
• Scientific literature from 2022 offers insights into FM's diagnosis, risk factors, comorbidities, and objective measures.
• Early identification and refined diagnostic tools are crucial for effective FM management.

Purpose of the Study:

• To review recent scientific findings on fibromyalgia (FM) published in 2022.
• To explore advancements in FM diagnosis, pathophysiology, and treatment strategies.
• To emphasize the importance of early detection and comprehensive management of FM.

Main Methods:

• Systematic review of scientific papers on fibromyalgia published in 2022 and indexed in PubMed.
• Analysis of diagnostic criteria, risk factors, comorbidities, and objective measurements.
• Evaluation of emerging treatment options, including pharmacological, neurostimulation, and lifestyle interventions.

Main Results:

• Recent studies focus on improving early FM diagnosis through physical and autonomic tests.
• Potential pathophysiological mechanisms include inflammation, gut dysbiosis, and neuroinflammation.
• Promising treatments include neurostimulation (TENS, tDCS, TMS), antioxidants, and nutritional interventions, though further research is needed.

Conclusions:

• Early diagnosis and improved objective measures are vital for managing fibromyalgia.
• Understanding the complex pathophysiology, including neuroinflammation and gut health, is key.
• A multimodal treatment approach incorporating neurostimulation, targeted medications, and nutritional strategies shows potential for symptom relief.